These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37175938)

  • 1. Androgen Receptor Imaging in the Management of Hormone-Dependent Cancers with Emphasis on Prostate Cancer.
    Kairemo K; Hodolic M
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron tomographic assessment of androgen receptors in prostatic carcinoma.
    Dehdashti F; Picus J; Michalski JM; Dence CS; Siegel BA; Katzenellenbogen JA; Welch MJ
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):344-50. PubMed ID: 15726353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging.
    Katzenellenbogen JA
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32718075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial [
    Boers J; Venema CM; de Vries EFJ; Hospers GAP; Boersma HH; Rikhof B; Dorbritz C; Glaudemans AWJM; Schröder CP
    Eur J Cancer; 2021 Feb; 144():151-161. PubMed ID: 33341447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of brain androgen receptors in rats: a [(18)F]FDHT PET study.
    Khayum MA; Doorduin J; Antunes IF; Kwizera C; Zijlma R; den Boer JA; Dierckx RA; de Vries EF
    Nucl Med Biol; 2015 Jun; 42(6):561-9. PubMed ID: 25735222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific
    Larimer BM; Dubois F; Bloch E; Nesti S; Placzek M; Zadra G; Hooker JM; Loda M; Mahmood U
    J Nucl Med; 2018 Oct; 59(10):1538-1543. PubMed ID: 29853654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET.
    Beattie BJ; Smith-Jones PM; Jhanwar YS; Schöder H; Schmidtlein CR; Morris MJ; Zanzonico P; Squire O; Meirelles GS; Finn R; Namavari M; Cai S; Scher HI; Larson SM; Humm JL
    J Nucl Med; 2010 Feb; 51(2):183-92. PubMed ID: 20080885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Evaluation of
    Antunes IF; Dost RJ; Hoving HD; van Waarde A; Dierckx RAJO; Samplonius DF; Helfrich W; Elsinga PH; de Vries EFJ; de Jong IJ
    J Nucl Med; 2021 Aug; 62(8):1140-1145. PubMed ID: 33517325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET).
    Bertolini R; Goepfert C; Andrieu T; Nichols S; Walter MA; Frey FJ; McCammon JA; Frey BM
    Prostate; 2015 Mar; 75(4):348-59. PubMed ID: 25358634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of steroid receptor expression in breast and prostate cancer.
    Hospers GA; Helmond FA; de Vries EG; Dierckx RA; de Vries EF
    Curr Pharm Des; 2008; 14(28):3020-32. PubMed ID: 18991716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
    Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
    J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.
    Venema CM; Mammatas LH; Schröder CP; van Kruchten M; Apollonio G; Glaudemans AWJM; Bongaerts AHH; Hoekstra OS; Verheul HMW; Boven E; van der Vegt B; de Vries EFJ; de Vries EGE; Boellaard R; Menke van der Houven van Oordt CW; Hospers GAP
    J Nucl Med; 2017 Dec; 58(12):1906-1912. PubMed ID: 28912144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 7alpha-(fluoromethyl)dihydrotestosterone and 7alpha-(fluoromethyl)nortestosterone, structurally paired androgens designed to probe the role of sex hormone binding globulin in imaging androgen receptors in prostate tumors by positron emission tomography.
    Parent EE; Carlson KE; Katzenellenbogen JA
    J Org Chem; 2007 Jul; 72(15):5546-54. PubMed ID: 17585812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metastases in castration-resistant prostate cancer: associations between morphologic CT patterns, glycolytic activity, and androgen receptor expression on PET and overall survival.
    Vargas HA; Wassberg C; Fox JJ; Wibmer A; Goldman DA; Kuk D; Gonen M; Larson SM; Morris MJ; Scher HI; Hricak H
    Radiology; 2014 Apr; 271(1):220-9. PubMed ID: 24475817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.
    Pandit-Taskar N; Veach DR; Fox JJ; Scher HI; Morris MJ; Larson SM
    J Nucl Med; 2016 Oct; 57(Suppl 3):73S-78S. PubMed ID: 27694177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer.
    Fox JJ; Gavane SC; Blanc-Autran E; Nehmeh S; Gönen M; Beattie B; Vargas HA; Schöder H; Humm JL; Fine SW; Lewis JS; Solomon SB; Osborne JR; Veach D; Sawyers CL; Weber WA; Scher HI; Morris MJ; Larson SM
    JAMA Oncol; 2018 Feb; 4(2):217-224. PubMed ID: 29121144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [
    Filippi L; Urso L; Schillaci O; Evangelista L
    Diagnostics (Basel); 2023 Aug; 13(15):. PubMed ID: 37568977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging Androgen Receptors in Breast Cancer with
    Jacene H; Liu M; Cheng SC; Abbott A; Dubey S; McCall K; Young D; Johnston M; Van den Abbeele AD; Overmoyer B
    J Nucl Med; 2022 Jan; 63(1):22-28. PubMed ID: 34049982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [7alpha-18F]fluoro-17alpha-methyl-5alpha-dihydrotestosterone: a ligand for androgen receptor-mediated imaging of prostate cancer.
    Garg PK; Labaree DC; Hoyte RM; Hochberg RB
    Nucl Med Biol; 2001 Jan; 28(1):85-90. PubMed ID: 11182568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.